Diabetes Drug Gets FDA Warning Due to Amputation Risk
WEDNESDAY, May 17, 2017 (HealthDay News) The type 2 diabetes prescription drug canagliflozin (brand names Invokana, Invokamet, Invokamet XR) appears to increase the risk of leg and foot amputations, the U.S. Food and Drug Administration now says. The FDA is requiring the medications to carry new...